Biology42: Generative Biologics is designed for creation at speed and scale.
With over 10 generative and predictive models, supported by physics-based tools, our platform produces novel, diverse, and high-quality biologics, and can effectively target hard-to-drug proteins and specific epitopes. Our method enables the generation of binder candidates in less than 24 hours, accelerating discovery where it matters most.

Identify the best candidates for further development by assessing their affinity and developability early in the discovery process.

Simultaneously optimize multiple properties of your biomolecules. Use our optimization workflow to balance both affinity and developability, leveraging a combination of built-in and user-trained models for tailored results.

Build project-specific models using your own data to achieve high-accuracy predictions and let AI guide your experiments, reducing both time and cost. Our proprietary models are designed to work with specific biologic types, achieving higher precision compared to traditional LLMs.